Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENVATINIB vs LETROZOLE\RIBOCICLIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LENVATINIB vs LETROZOLE\RIBOCICLIB: Safety Overview

Metric LENVATINIB LETROZOLE\RIBOCICLIB
Total FAERS Reports 33,766 621
Deaths Reported 4,449 78
Death Rate 13.2% 12.6%
Hospitalizations 19,975 80
Average Patient Age 65.4 yrs 64.2 yrs
% Female Patients 55.8% 98.2%
FDA Approval Date Feb 13, 2015 N/A
Manufacturer Eisai Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A